Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle

BACKGROUND: The purpose of this study was to evaluate cell cycle changes in choroidal endothelial cells treated with varying doses of bevacizumab in the presence of a range of concentrations of vascular endothelial growth factor (VEGF). Bevacizumab, a drug widely used in the treatment of neovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Rusovici, Raluca, Patel, Chirag J, Chalam, Kakarla V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575188/
https://www.ncbi.nlm.nih.gov/pubmed/23430458
http://dx.doi.org/10.2147/OPTH.S41556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575188/
https://www.ncbi.nlm.nih.gov/pubmed/23430458
http://dx.doi.org/10.2147/OPTH.S41556

Ejemplares similares